NOVUS THERAPEUTICS INC's ticker is NVUS and the CUSIP is 67011N105. A total of 21 filers reported holding NOVUS THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lyon Street Capital, LLC | 90,199 | $421,000 | 0.26% |
Boxer Capital, LLC | 324,383 | $1,515,000 | 0.17% |
Orbimed Advisors | 2,537,110 | $11,848,000 | 0.14% |
RTW INVESTMENTS, LP | 316,257 | $1,477,000 | 0.09% |
B. Riley Wealth Advisors, Inc. | 45,000 | $211,000 | 0.02% |
Sequoia Financial Advisors, LLC | 17,500 | $82,000 | 0.01% |
Renaissance Technologies | 251,556 | $1,175,000 | 0.00% |
VANGUARD GROUP INC | 135,599 | $633,000 | 0.00% |
D. E. Shaw & Co., Inc. | 12,499 | $58,000 | 0.00% |
RAYMOND JAMES & ASSOCIATES | 10,944 | $51,000 | 0.00% |